Article
Genetic heterogeneity of the envelope 2 gene and eradication of hepatitis C virus after a second course of interferon-alpha.
Journal of medical virology - 1 Oct 2002
Boulestin Anne, Sandres-Sauné Karine, Payen Jean-Louis, Alric Laurent, Dubois Martine, Pasquier Christophe, Vinel Jean-Pierre, Pascal Jean-Pierre, Puel Jacqueline, Izopet Jacques
Abstract excerpt
The heterogeneity of the envelope 2 (E2) gene of the hepatitis C virus (HCV) was involved in the sensitivity of HCV to interferon-alpha (IFN-alpha). To assess the factors leading to virus eradication by IFN-alpha, patients whose first treatment by IFN-alpha failed and who had virus eradication after a second treatment were studied. These patients were paired with subjects in whom both treatments failed. The...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
